Regeneron Pharmaceuticals said it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA data #News #Reuters #Newsfeed Read the story here: https://reut.rs/4dn3wyG 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/

Tag-uri: Facebook DNA Twitter